7LV-22040-73937
2 vaccinations
5 coded responses
22 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 973 / OR
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Survey response — day 0, dose 1MedDRA: Dizziness — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Lightheadedness following injection that resolved in 15-20 min.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-01-10
-
2021-01-13
Survey response — days 1–6 daily, dose 1MedDRA: Nausea, Vertigo — Feeling: Good · NauseaFree text: Last night I had an intense vertigo episode paired with nausea. This is not uncommon for me but the duration was longer than usual.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-17
- 2021-01-22
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-01-29
Survey response — day 0, dose 2MedDRA: Nasal congestion — Feeling: Good · Site: Pain · HeadacheFree text: Nasal CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Fever · Chills, DiarrheaFree text: Rapid body temp rises (5-10 degrees all under fever level)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-04-30
- 2021-07-30
-
2022-01-31
Survey response — 12 months, dose 2MedDRA: Cough, Exposure to SARS-CoV-2, Fatigue, Laboratory test abnormal, Oropharyngeal pain, Pain, Pyrexia, Respiratory tract congestion, Throat irritation — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had a presumptive positive case of COVID-19 following an exposure. At the time I had itchy/sore throat, cough, congestion, fatigue, low grade fever and body aches. Most symptoms subsided in 6-7 days. Negative test results though other were positive.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Lightheadedness following injection that resolved in 15-20 min.
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Last night I had an intense vertigo episode paired with nausea. This is not uncommon for me but the duration was longer than usual.
Release 3 — day 0, dose 2
Systemic reaction (other): Nasal Congestion
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Rapid body temp rises (5-10 degrees all under fever level)
Release 11 — 12 months, dose 2
Symptoms: Had a presumptive positive case of COVID-19 following an exposure. At the time I had itchy/sore throat, cough, congestion, fatigue, low grade fever and body aches. Most symptoms subsided in 6-7 days. Negative test results though other were positive. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release